These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8139451)

  • 1. Relaxometry, animal biodistribution, and magnetic resonance imaging studies of some new gadolinium (III) macrocyclic phosphinate and phosphonate monoester complexes.
    Geraldes CF; Sherry AD; Lázár I; Miseta A; Bogner P; Berenyi E; Sumegi B; Kiefer GE; McMillan K; Maton F
    Magn Reson Med; 1993 Dec; 30(6):696-703. PubMed ID: 8139451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of polyaza macrocyclic methylene phosphonate chelates of Gd3+ ions as MRI contrast agents.
    Geraldes CF; Brown RD; Cacheris WP; Koenig SH; Sherry AD; Spiller M
    Magn Reson Med; 1989 Jan; 9(1):94-104. PubMed ID: 2540397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gadolinium(III) complexes of mono- and diethyl esters of monophosphonic acid analogue of DOTA as potential MRI contrast agents: solution structures and relaxometric studies.
    Lebdusková P; Hermann P; Helm L; Tóth E; Kotek J; Binnemans K; Rudovský J; Lukes I; Merbach AE
    Dalton Trans; 2007 Jan; (4):493-501. PubMed ID: 17213936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging.
    Chong HS; Garmestani K; Bryant LH; Milenic DE; Overstreet T; Birch N; Le T; Brady ED; Brechbiel MW
    J Med Chem; 2006 Mar; 49(6):2055-62. PubMed ID: 16539394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclen-based Gd
    Rashid HU; Martines MAU; Jorge J; de Moraes PM; Umar MN; Khan K; Rehman HU
    Bioorg Med Chem; 2016 Nov; 24(22):5663-5684. PubMed ID: 27729196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel gadolinium(III) polyaminocarboxylate macrocyclic complexes as potential magnetic resonance imaging contrast agents.
    Chan KW; Barra S; Botta M; Wong WT
    J Inorg Biochem; 2004 May; 98(5):677-82. PubMed ID: 15134912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrocyclic Gd3+ chelates attached to a silsesquioxane core as potential magnetic resonance imaging contrast agents: synthesis, physicochemical characterization, and stability studies.
    Henig J; Tóth E; Engelmann J; Gottschalk S; Mayer HA
    Inorg Chem; 2010 Jul; 49(13):6124-38. PubMed ID: 20527901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution profile of gadolinium in gadolinium chelate-treated renally-impaired rats: role of pharmaceutical formulation.
    Fretellier N; Salhi M; Schroeder J; Siegmund H; Chevalier T; Bruneval P; Jestin-Mayer G; Delaloge F; Factor C; Mayer JF; Fabicki JM; Robic C; Bonnemain B; Idée JM; Corot C
    Eur J Pharm Sci; 2015 May; 72():46-56. PubMed ID: 25736527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats.
    Tweedle MF; Wedeking P; Kumar K
    Invest Radiol; 1995 Jun; 30(6):372-80. PubMed ID: 7490190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
    Caravan P
    Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lanthanide chelates of (bis)-hydroxymethyl-substituted DTTA with potential application as contrast agents in magnetic resonance imaging.
    Silvério S; Torres S; Martins AF; Martins JA; André JP; Helm L; Prata MI; Santos AC; Geraldes CF
    Dalton Trans; 2009 Jun; (24):4656-70. PubMed ID: 19513474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tris(pyrone) chelates of Gd(III) as high solubility MRI-CA.
    Puerta DT; Botta M; Jocher CJ; Werner EJ; Avedano S; Raymond KN; Cohen SM
    J Am Chem Soc; 2006 Feb; 128(7):2222-3. PubMed ID: 16478170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of a phosphodiester linking group on albumin binding, blood half-life, and relaxivity of intravascular diethylenetriaminepentaacetato aquo gadolinium(III) MRI contrast agents.
    McMurry TJ; Parmelee DJ; Sajiki H; Scott DM; Ouellet HS; Walovitch RC; Tyeklár Z; Dumas S; Bernard P; Nadler S; Midelfort K; Greenfield M; Troughton J; Lauffer RB
    J Med Chem; 2002 Aug; 45(16):3465-74. PubMed ID: 12139457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new biodegradable and biocompatible gadolinium (III) -polymer for liver magnetic resonance imaging contrast agent.
    Xiao Y; Xue R; You T; Li X; Pei F
    Magn Reson Imaging; 2015 Jul; 33(6):822-8. PubMed ID: 25839395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and relaxometry of high-generation (G = 5, 7, 9, and 10) PAMAM dendrimer-DOTA-gadolinium chelates.
    Bryant LH; Brechbiel MW; Wu C; Bulte JW; Herynek V; Frank JA
    J Magn Reson Imaging; 1999 Feb; 9(2):348-52. PubMed ID: 10077036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical and biological evaluation of 153Sm and 166Ho complexes of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylphosphonic acid monoethylester) (H4 dotp OEt).
    Försterová M; Jandurová Z; Marques F; Gano L; Lubal P; Vanek J; Hermann P; Santos I
    J Inorg Biochem; 2008 Jul; 102(7):1531-40. PubMed ID: 18374985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Gd3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon.
    Hanaoka K; Kikuchi K; Terai T; Komatsu T; Nagano T
    Chemistry; 2008; 14(3):987-95. PubMed ID: 17992679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bifunctional Gd(III) and Tb(III) chelates based on a pyridine-bis(iminodiacetate) platform, suitable optical probes and contrast agents for magnetic resonance imaging.
    Laurent S; Vander Elst L; Galaup C; Leygue N; Boutry S; Picard C; Muller RN
    Contrast Media Mol Imaging; 2014; 9(4):300-12. PubMed ID: 24706614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new macrocyclic MRI contrast agent: Gd MCTA complex.
    Schaefer M; Meyer D; Beaute S; Doucet D
    Magn Reson Med; 1991 Dec; 22(2):238-41. PubMed ID: 1812352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of gadolinium 2,5-BPA-DO3A, a new macrocyclic hepatobiliary chelate, in normal liver and metastatic disease on high field magnetic resonance imaging.
    Runge VM; Wells JW; Williams NM
    Invest Radiol; 1996 Jan; 31(1):11-6. PubMed ID: 8850360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.